Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis (Histone)
Status
Conditions
Details and patient eligibility
About
In an effort to better understand the interaction between the different mediators, the investigators propose to examine the time course of mediators, the indexes of organ injury and the coagulation cascade.
Full description
All patients admitted to the ICU (Including VA Medical Center, University Hospital and Presbyterian hospital) will be screened for enrollment in the study. Patients who have the diagnosis of sepsis will be asked to volunteer. We will match sepsis patients with other ICU patients without the diagnosis of sepsis. The latter will also be asked to volunteer.
Patients will be stratified into three groups:
- Sepsis
- SIRS of non-septic origin
- Other ICU patients
Routine laboratory data and clinical data (see flow sheet) will be collected. The plasma or serum will be frozen separately until the target number of patients is met. Measurements of inflammatory mediators and other cytokines/injury markers will be carried out at that point.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Admission to the ICU
Exclusion criteria
- No blood draws scheduled
- Hemoglobin level < 6.5 gm/dl
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal